Quiescence in R3327-G Rat prostate tumors after androgen ablation

Alan Pollack, Daryl Lim Joon, Catherine S. Wu, Charles Sikes, Masatoshi Hasegawa, Nicholas H A Terry, R. Allen White, Gunar K. Zagars, Marvin L. Meistrich

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Androgen ablation is frequently used in conjunction with radiotherapy in the treatment of high-risk prostate cancer. Androgen ablation-induced cell kinetic changes could result in sub-additive (increased quiescence) or supra- additive (reduction in repopulation) interactions with radiotherapy. The cell kinetic changes were studied in R3327-G Dunning rat prostate tumors grown in vivo using double thymidine analogue labeling and flow cytometry, the terminal deoxynucleotidyl transferase-mediated nick end labeling assay for apoptosis, and measurements of tumor cell numbers. Tumors grown in intact and castrate male rats were continuously labeled for various periods of time with chlorodeoxyuridine and pulse-labeled with iododeoxyuridine 8 h before tumor removal. Androgen ablation resulted in a maximal reduction in labeling index (10 to 1.6%) and an increase in potential doubling time (Tpot; 6-42 days) within 3 days, which was related to a reduction in growth fraction (65% to < 10%). In contrast, the length of S-phase was minimally altered (19 to 23 h). The response to androgen ablution involved little apoptosis and no necrosis, and Tpot was approximately the same as the tumor volume doubling time. Hence, the increase in Tpot was mainly the result of a shift to quiescence, and this shift occurred with minimal cell loss. Because quiescence is usually associated with radioresistance, these cell kinetic changes suggest that a sub-additive interaction may occur for some prostate cancers when androgen ablution and irradiation are given together.

Original languageEnglish
Pages (from-to)2493-2500
Number of pages8
JournalCancer Research
Volume57
Issue number12
StatePublished - Jun 15 1997
Externally publishedYes

Fingerprint

Androgens
Prostate
Neoplasms
Prostatic Neoplasms
Radiotherapy
Apoptosis
Idoxuridine
DNA Nucleotidylexotransferase
Tumor Burden
S Phase
Thymidine
Flow Cytometry
Necrosis
Cell Count
Growth
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Pollack, A., Lim Joon, D., Wu, C. S., Sikes, C., Hasegawa, M., Terry, N. H. A., ... Meistrich, M. L. (1997). Quiescence in R3327-G Rat prostate tumors after androgen ablation. Cancer Research, 57(12), 2493-2500.

Quiescence in R3327-G Rat prostate tumors after androgen ablation. / Pollack, Alan; Lim Joon, Daryl; Wu, Catherine S.; Sikes, Charles; Hasegawa, Masatoshi; Terry, Nicholas H A; White, R. Allen; Zagars, Gunar K.; Meistrich, Marvin L.

In: Cancer Research, Vol. 57, No. 12, 15.06.1997, p. 2493-2500.

Research output: Contribution to journalArticle

Pollack, A, Lim Joon, D, Wu, CS, Sikes, C, Hasegawa, M, Terry, NHA, White, RA, Zagars, GK & Meistrich, ML 1997, 'Quiescence in R3327-G Rat prostate tumors after androgen ablation', Cancer Research, vol. 57, no. 12, pp. 2493-2500.
Pollack A, Lim Joon D, Wu CS, Sikes C, Hasegawa M, Terry NHA et al. Quiescence in R3327-G Rat prostate tumors after androgen ablation. Cancer Research. 1997 Jun 15;57(12):2493-2500.
Pollack, Alan ; Lim Joon, Daryl ; Wu, Catherine S. ; Sikes, Charles ; Hasegawa, Masatoshi ; Terry, Nicholas H A ; White, R. Allen ; Zagars, Gunar K. ; Meistrich, Marvin L. / Quiescence in R3327-G Rat prostate tumors after androgen ablation. In: Cancer Research. 1997 ; Vol. 57, No. 12. pp. 2493-2500.
@article{002d81c8443e4ebfbd1fa4dfb310b952,
title = "Quiescence in R3327-G Rat prostate tumors after androgen ablation",
abstract = "Androgen ablation is frequently used in conjunction with radiotherapy in the treatment of high-risk prostate cancer. Androgen ablation-induced cell kinetic changes could result in sub-additive (increased quiescence) or supra- additive (reduction in repopulation) interactions with radiotherapy. The cell kinetic changes were studied in R3327-G Dunning rat prostate tumors grown in vivo using double thymidine analogue labeling and flow cytometry, the terminal deoxynucleotidyl transferase-mediated nick end labeling assay for apoptosis, and measurements of tumor cell numbers. Tumors grown in intact and castrate male rats were continuously labeled for various periods of time with chlorodeoxyuridine and pulse-labeled with iododeoxyuridine 8 h before tumor removal. Androgen ablation resulted in a maximal reduction in labeling index (10 to 1.6{\%}) and an increase in potential doubling time (Tpot; 6-42 days) within 3 days, which was related to a reduction in growth fraction (65{\%} to < 10{\%}). In contrast, the length of S-phase was minimally altered (19 to 23 h). The response to androgen ablution involved little apoptosis and no necrosis, and Tpot was approximately the same as the tumor volume doubling time. Hence, the increase in Tpot was mainly the result of a shift to quiescence, and this shift occurred with minimal cell loss. Because quiescence is usually associated with radioresistance, these cell kinetic changes suggest that a sub-additive interaction may occur for some prostate cancers when androgen ablution and irradiation are given together.",
author = "Alan Pollack and {Lim Joon}, Daryl and Wu, {Catherine S.} and Charles Sikes and Masatoshi Hasegawa and Terry, {Nicholas H A} and White, {R. Allen} and Zagars, {Gunar K.} and Meistrich, {Marvin L.}",
year = "1997",
month = "6",
day = "15",
language = "English",
volume = "57",
pages = "2493--2500",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "12",

}

TY - JOUR

T1 - Quiescence in R3327-G Rat prostate tumors after androgen ablation

AU - Pollack, Alan

AU - Lim Joon, Daryl

AU - Wu, Catherine S.

AU - Sikes, Charles

AU - Hasegawa, Masatoshi

AU - Terry, Nicholas H A

AU - White, R. Allen

AU - Zagars, Gunar K.

AU - Meistrich, Marvin L.

PY - 1997/6/15

Y1 - 1997/6/15

N2 - Androgen ablation is frequently used in conjunction with radiotherapy in the treatment of high-risk prostate cancer. Androgen ablation-induced cell kinetic changes could result in sub-additive (increased quiescence) or supra- additive (reduction in repopulation) interactions with radiotherapy. The cell kinetic changes were studied in R3327-G Dunning rat prostate tumors grown in vivo using double thymidine analogue labeling and flow cytometry, the terminal deoxynucleotidyl transferase-mediated nick end labeling assay for apoptosis, and measurements of tumor cell numbers. Tumors grown in intact and castrate male rats were continuously labeled for various periods of time with chlorodeoxyuridine and pulse-labeled with iododeoxyuridine 8 h before tumor removal. Androgen ablation resulted in a maximal reduction in labeling index (10 to 1.6%) and an increase in potential doubling time (Tpot; 6-42 days) within 3 days, which was related to a reduction in growth fraction (65% to < 10%). In contrast, the length of S-phase was minimally altered (19 to 23 h). The response to androgen ablution involved little apoptosis and no necrosis, and Tpot was approximately the same as the tumor volume doubling time. Hence, the increase in Tpot was mainly the result of a shift to quiescence, and this shift occurred with minimal cell loss. Because quiescence is usually associated with radioresistance, these cell kinetic changes suggest that a sub-additive interaction may occur for some prostate cancers when androgen ablution and irradiation are given together.

AB - Androgen ablation is frequently used in conjunction with radiotherapy in the treatment of high-risk prostate cancer. Androgen ablation-induced cell kinetic changes could result in sub-additive (increased quiescence) or supra- additive (reduction in repopulation) interactions with radiotherapy. The cell kinetic changes were studied in R3327-G Dunning rat prostate tumors grown in vivo using double thymidine analogue labeling and flow cytometry, the terminal deoxynucleotidyl transferase-mediated nick end labeling assay for apoptosis, and measurements of tumor cell numbers. Tumors grown in intact and castrate male rats were continuously labeled for various periods of time with chlorodeoxyuridine and pulse-labeled with iododeoxyuridine 8 h before tumor removal. Androgen ablation resulted in a maximal reduction in labeling index (10 to 1.6%) and an increase in potential doubling time (Tpot; 6-42 days) within 3 days, which was related to a reduction in growth fraction (65% to < 10%). In contrast, the length of S-phase was minimally altered (19 to 23 h). The response to androgen ablution involved little apoptosis and no necrosis, and Tpot was approximately the same as the tumor volume doubling time. Hence, the increase in Tpot was mainly the result of a shift to quiescence, and this shift occurred with minimal cell loss. Because quiescence is usually associated with radioresistance, these cell kinetic changes suggest that a sub-additive interaction may occur for some prostate cancers when androgen ablution and irradiation are given together.

UR - http://www.scopus.com/inward/record.url?scp=15144346419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15144346419&partnerID=8YFLogxK

M3 - Article

C2 - 9192831

AN - SCOPUS:15144346419

VL - 57

SP - 2493

EP - 2500

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 12

ER -